0000899243-18-002335.txt : 20180130
0000899243-18-002335.hdr.sgml : 20180130
20180130210302
ACCESSION NUMBER: 0000899243-18-002335
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180130
FILED AS OF DATE: 20180130
DATE AS OF CHANGE: 20180130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pomerantz Roger
CENTRAL INDEX KEY: 0001614936
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37465
FILM NUMBER: 18560728
MAIL ADDRESS:
STREET 1: 711 HARVEST HILL ROAD
CITY: CHALFONT
STATE: PA
ZIP: 18914
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Seres Therapeutics, Inc.
CENTRAL INDEX KEY: 0001609809
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 274326290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617 945 9626
MAIL ADDRESS:
STREET 1: 200 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Seres Health, Inc.
DATE OF NAME CHANGE: 20140603
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-01-30
0
0001609809
Seres Therapeutics, Inc.
MCRB
0001614936
Pomerantz Roger
C/O SERES THERAPEUTICS, INC.
200 SIDNEY STREET
CAMBRIDGE
MA
02139
1
1
0
0
President and CEO
Stock Option (right to buy)
10.42
2018-01-30
4
A
0
278000
0.00
D
2028-01-29
Common Stock
278000
278000
D
The option will vest as to 25% of the shares on January 30, 2019. The remainder of the shares will vest in 12 equal quarterly installments thereafter.
/s/ Thomas J. DesRosier, Attorney-in-Fact
2018-01-30